Larkspur Biosciences Funding & Investors
Watertown, MA
Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
larkspur.bioTotal Amount Raised: $35,500,000
Larkspur Biosciences Funding Rounds
Series A
$35,500,000
Series A Investors
3E Bioventures CapitalPolaris PartnersTakeda Ventures
Funding info provided by Diffbot.